Michael Kovacs - Net Worth and Insider Trading
Michael Kovacs Net Worth
The estimated net worth of Michael Kovacs is at least $0 dollars as of 2024-11-13. Michael Kovacs is the Director, Senior Officer of Big Pharma Split Corp and owns about 0 shares of Big Pharma Split Corp (TSX:PRM) stock worth over $0. Details can be seen in Michael Kovacs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Kovacs has not made any transactions after 2019-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Kovacs
Michael Kovacs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Kovacs owns 1 companies in total, including Big Pharma Split Corp (TSX:PRM) .
Click here to see the complete history of Michael Kovacs’s form 4 insider trades.
Insider Ownership Summary of Michael Kovacs
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:PRM | Big Pharma Split Corp | 2019-10-07 | Director & Senior Officer |
Michael Kovacs Latest Holdings Summary
Michael Kovacs currently owns a total of 1 stock. Michael Kovacs owns 0 shares of Big Pharma Split Corp (TSX:PRM) as of October 7, 2019, with a value of $0.
Latest Holdings of Michael Kovacs
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:PRM | Big Pharma Split Corp | 2019-10-07 | 0 | 13.15 | 0 |
Holding Weightings of Michael Kovacs
Michael Kovacs Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Kovacs has made a total of 0 transactions in Big Pharma Split Corp (TSX:PRM) over the past 5 years. The most-recent trade in Big Pharma Split Corp is the sale of 1,500 shares on October 7, 2019, which brought Michael Kovacs around $17,850.
Insider Trading History of Michael Kovacs
- 1
Michael Kovacs Trading Performance
GuruFocus tracks the stock performance after each of Michael Kovacs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Kovacs is -0.3%. GuruFocus also compares Michael Kovacs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Kovacs within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Kovacs's insider trading performs compared to the benchmark.
Performance of Michael Kovacs
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.12 | | | | | |
| Relative Return to S&P 500(%) | 1.76 | | | | | |
Michael Kovacs Ownership Network
Ownership Network List of Michael Kovacs
Ownership Network Relation of Michael Kovacs
Michael Kovacs Owned Company Details
What does Big Pharma Split Corp do?
Who are the key executives at Big Pharma Split Corp?
Michael Kovacs is the Director & Senior Officer of Big Pharma Split Corp.
Big Pharma Split Corp (TSX:PRM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Big Pharma Split Corp (TSX:PRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Big Pharma Split Corp (TSX:PRM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Big Pharma Split Corp (TSX:PRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Big Pharma Split Corp Insider Transactions
Michael Kovacs Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Kovacs. Currently GuruFocus does not have mailing address information for Michael Kovacs.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
